New network Oxford Cancer launches
14 July 2021
OxCODE is working under the umbrella of a new pan-divisional initiative at the University of Oxford that brings together the collective force of cancer research, outreach and care that happen across the city of Oxford.
Development of accurate long-read single-cell sequencing
1 July 2021
Researchers at the Botnar Research Centre have developed technology that facilitates standalone long-read Oxford Nanopore sequencing of single cells, opening avenues for understanding the causes of diseases like cancer.
Early diagnosis of lymphoma in children and young adults in sub-Saharan Africa
23 June 2021
Professor Anna Schuh’s research is featured in a case study by the National Institute for Health Research
Clinical academic research partnership to improve myeloma early diagnosis
22 June 2021
Congratulations to Dr Karthik Ramasamy for his £270,000 award from the Medical Research Council.
Oxford University and partners win government funding to evaluate Paige Prostate Cancer Detection System
16 June 2021
A prostate cancer detection software system to help pathologists quickly identify suspicious areas of tissue, developed by Paige, will be investigated in a multicentre clinical study led by Oxford University as part of a successful NHSx Artificial Intelligence Health and Care Award application.
AI endoscopy enables 3D surface measurements of pre-cancerous condition in oesophagus
9 June 2021
Clinicians and engineers in Oxford have begun using artificial intelligence alongside endoscopy to get more accurate readings of the pre-cancerous condition Barrett’s oesophagus and so determine patients most at risk of developing cancer.
Artificial intelligence tool for streamlining pathology workflow
26 May 2021
A multidisciplinary team, comprising Andrea Chatrian, Dr Richard Colling, Professor Clare Verrill, Professor Jens Rittscher and colleagues, develops an algorithm for automated requesting of additional investigation in diagnostically uncertain prostate biopsies.
Funding success for Oxford’s early cancer detection researchers
25 May 2021
Nine OxCODE members have recently been awarded funding for their early detection research.
Professor David Hunter honoured by the Academy of Medical Sciences
13 May 2021
OxCODE Associate Director Professor David Hunter has been elected as a Fellow of the Academy of Medical Sciences.
Prostate cancer risk tool
11 May 2021
A new calculator has been developed by Professors Julia Hippisley-Cox and Carol Coupland to help GPs prioritise patients at high risk of prostate cancer.
Understanding mutation progression to detect ovarian cancer earlier
7 May 2021
Nina Wietek from the Ahmed lab is investigating fallopian tube tissue to see what we can understand about precancerous mutations in the tissue from which ovarian cancers develops.
Ludwig-Oxford Symposium on Cancer Early Detection and Epigenetics – a recap
7 May 2021
On 28-29th April 2021, we heard the latest developments from international leaders in these fields from the University of Oxford, Ludwig Cancer Research and beyond.
New method for cost-effective genome-wide DNA methylation analysis
28 April 2021
Dr Chunxiao Song’s team build on its TAPS method to develop an alternative to costly whole-genome sequencing for the detection of DNA methylation.
Oxford success at the early detection sandpit on pancreatic cancer
21 April 2021
Professor Eric O’Neill and Dr Pui San Tan receive funding as part of teams applying novel approaches for the early detection of pancreatic cancer.
New clinical prediction tools for myeloma
8 April 2021
Dr Constantinos Koshiaris has developed clinical prediction models for use in primary care with the aim of accelerating myeloma diagnoses.
CRUK Early Detection Primer Award for research into the clinical application of single cell genomics
6 April 2021
Dr Onima Chowdhury will investigate the clinical application of single cell sequencing for early diagnosis and response prediction in myelodysplastic syndromes.
High testosterone levels in men linked to increased melanoma risk
2 April 2021
Research by Dr Eleanor Watts using UK Biobank data has uncovered this association for the first time
FDA clearance for Oxford spin-out’s early lung cancer diagnosis software
29 March 2021
Optellum, an Oxford-based lung health company aiming to redefine early diagnosis and treatment of lung disease, has received FDA clearance for its AI-powered clinical decision support software.
New funding for early diagnosis research using platelets
29 March 2021
Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.
Funding to improve childhood, teenage and young adult cancer detection
25 March 2021
Dr Defne Saatci and Professor Julia Hippisley-Cox will develop risk prediction tools using the QResearch database to support the earlier detection of childhood, teenage and young adult cancer